Literature DB >> 17102008

Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia.

Marcel N Menke1, Gilbert T Feke, J Wallace McMeel, Andrew Branagan, Zachary Hunter, Steven P Treon.   

Abstract

OBJECTIVES: To determine the earliest retinal changes associated with Waldenström macroglobulinemia (WM) and to ascertain the serum IgM and serum viscosity (SV) levels at which these changes occur.
METHODS: Patients with WM were evaluated using indirect ophthalmoscopy with scleral depression, laser Doppler retinal blood flow measurements, and serum IgM and SV determinations. Hemodynamic findings were compared with those of a group of age-matched controls. A retinopathy severity scale was developed, and the associated IgM and SV values were related to particular morphologic changes.
RESULTS: A total of 46 patients with WM and 14 age-matched, healthy controls participated in the study. Patients exhibited far-peripheral hemorrhages and venous dilation with increasing SV and IgM values. Central retinal changes were associated with significantly higher SV values. Retinal vessel diameter increased with increasing serum IgM and SV levels. The mean IgM level of patients with the earliest retinal changes was 5442 mg/dL. The mean SV level was 3.1 cP.
CONCLUSIONS: Retinal manifestations of hyperviscosity syndrome occur at lower serum IgM and SV levels than previously reported. Indirect ophthalmoscopy with scleral depression along with retinal vessel diameter measurements are able to detect the earliest hyperviscosity syndrome-related complications and should be considered in the treatment of patients with WM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102008     DOI: 10.1001/archopht.124.11.1601

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

Review 1.  Acute hyperviscosity: syndromes and management.

Authors:  Morie A Gertz
Journal:  Blood       Date:  2018-08-13       Impact factor: 22.113

2.  Peripheral capillary non-perfusion in asymptomatic Waldenström's macroglobulinemia.

Authors:  Chryssanthi Koutsandrea; Athanasios Kotsolis; Ilias Georgalas; Dimitris Papaconstantinou; Ioannis Ladas
Journal:  BMC Ophthalmol       Date:  2010-12-03       Impact factor: 2.209

3.  Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenström's macroglobulinemia.

Authors:  Lucy T Xu; Robert J Courtney; Justis P Ehlers
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-02       Impact factor: 1.300

4.  Multimodal imaging in immunogammopathy maculopathy secondary to Waldenstrom's macroglobulinemia: a case report.

Authors:  Hui-Rong Xu; Jie Zhu; Xiao-Yan Xie; Jun Zhu; Fang Chen
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

5.  Fatal cerebral hemorrhage in a patient with CD19-positive IgM-producing aggressive plasma cell myeloma, hyperviscosity syndrome and cryoglobulinemia.

Authors:  Adnan Alatoom; Rania Elsabrouty; Jason Willis; Christie Boils; Ravindra Sarode; Ibrahim Hashim; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2009-02-09

6.  Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease.

Authors:  Vito Fenicia; Marco Balestrieri; Andrea Perdicchi; Giorgia Maraone; Santi Maria Recupero
Journal:  Case Rep Ophthalmol       Date:  2013-07-26

Review 7.  Waldenstrom's Macroglobulinemia: An Update.

Authors:  Maddalena Mazzucchelli; Anna Maria Frustaci; Marina Deodato; Roberto Cairoli; Alessandra Tedeschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

8.  Waldenstrom's Macroglobulinemia: A Report of Two Cases, One with Severe Retinopathy and One with Renal Failure.

Authors:  Naoko Kudo; Masakatsu Usui; Yukiharu Nakabo; Ken-Ichi Yoshida; Kenji Miki; Takashi Osafune; Keisuke Nishimura; Shinsaku Imashuku
Journal:  Case Rep Hematol       Date:  2017-10-31

9.  Localized retinal degeneration secondary to Waldenström's macroglobulinemia.

Authors:  Dhanashree Ratra; Vineet Ratra; Mansi Kishnani
Journal:  Oman J Ophthalmol       Date:  2017 Sep-Dec

10.  Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis.

Authors:  Michael J Schatz; Carl S Wilkins; Oscar Otero-Marquez; Toco Y P Chui; Richard B Rosen; Meenakashi Gupta
Journal:  Case Rep Ophthalmol Med       Date:  2021-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.